Paper42568005
Corpus callosum fractional anisotropy from routine diffusion tensor imaging predicts dementia in older adults beyond clinical risk factors.
Negev S and 9 others. Geroscience, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Corpus callosum fractional anisotropy from routine diffusion tensor imaging predicts dementia in older adults beyond clinical risk factors. Papers, record 42568005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42568005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Corpus callosum fractional anisotropy from routine diffusion tensor imaging predicts dementia in older adults beyond clinical risk factors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39174535 | Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39174535 | PubMed |
| 2 | 39236855 | Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier. | Ageing Res Rev | 2024 | https://conductscience.org/library/papers/39236855 | PubMed |
| 3 | 39790124 | Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: current and future perspective. | RSC Med Chem | 2025 | https://conductscience.org/library/papers/39790124 | PubMed |
| 4 | 37009740 | The Neurovasculome: Key Roles in Brain Health and Cognitive Impairment: A Scientific Statement From the American Heart Association/American Stroke Association. | Stroke | 2023 | https://conductscience.org/library/papers/37009740 | PubMed |
| 5 | 40513084 | White Matter Abnormalities and Cognition in Aging and Alzheimer Disease. | JAMA Neurol | 2025 | https://conductscience.org/library/papers/40513084 | PubMed |
| 6 | 39882349 | Associations of modifiable dementia risk factors with dementia and cognitive decline: evidence from three prospective cohorts. | Front Public Health | 2025 | https://conductscience.org/library/papers/39882349 | PubMed |
| 7 | 39096926 | Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. | Lancet | 2024 | https://conductscience.org/library/papers/39096926 | PubMed |
| 8 | 37647064 | CogDrisk, ANU-ADRI, CAIDE, and LIBRA Risk Scores for Estimating Dementia Risk. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37647064 | PubMed |
| 9 | 40715606 | Clinical prediction models using artificial intelligence approaches in dementia. | Aging Clin Exp Res | 2025 | https://conductscience.org/library/papers/40715606 | PubMed |
| 10 | 40140622 | Blood-based biomarkers of Alzheimer's disease and incident dementia in the community. | Nat Med | 2025 | https://conductscience.org/library/papers/40140622 | PubMed |
| 11 | 36875694 | Reconsidering the role of blood-brain barrier in Alzheimer's disease: From delivery to target. | Front Aging Neurosci | 2023 | https://conductscience.org/library/papers/36875694 | PubMed |
| 12 | 41363873 | Role of Blood-Brain Barrier Permeability in Delirium Pathophysiology and Treatment. | Anesthesiology | 2026 | https://conductscience.org/library/papers/41363873 | PubMed |
| 13 | 25120476 | Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy. | Front Aging Neurosci | 2014 | https://conductscience.org/library/papers/25120476 | PubMed |
| 14 | 40210862 | Blood-brain barrier biomarkers modulate the associations of peripheral immunity with Alzheimer's disease. | Transl Psychiatry | 2025 | https://conductscience.org/library/papers/40210862 | PubMed |
| 15 | 38003477 | Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003477 | PubMed |
| 16 | 39860392 | The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications. | J Clin Med | 2025 | https://conductscience.org/library/papers/39860392 | PubMed |
| 17 | 36077024 | Glutamate Neurotoxicity and Destruction of the Blood-Brain Barrier: Key Pathways for the Development of Neuropsychiatric Consequences of TBI and Their Potential Treatment Strategies. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077024 | PubMed |
| 18 | 39056809 | The Role of Glutamate and Blood-Brain Barrier Disruption as a Mechanistic Link between Epilepsy and Depression. | Cells | 2024 | https://conductscience.org/library/papers/39056809 | PubMed |
| 19 | 36982969 | The Integrity of the Blood-Brain Barrier as a Critical Factor for Regulating Glutamate Levels in Traumatic Brain Injury. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982969 | PubMed |
| 20 | 39771027 | Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity. | Nutrients | 2024 | https://conductscience.org/library/papers/39771027 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42568005
GET https://conductscience.org/api/papers/v1/42568005/references?page=2